Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Thrombocytopenia 1Neutropenia 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Anemia 1

Interventions

eltrombopag 9avatrombopag 6Platelet Transfusion 6romiplostim 4Tranexamic Acid 3Radiotherapy 3Cytarabine 3oprelvekin 2hetrombopag 2Tretinoin 2Peripheral Blood Stem Cell Transplantation 2Filgrastim 2Cyclophosphamide 2Carboplatin 2Busulfan 2Amplified Fragment Length Polymorphism Analysis 2sodium thiosulfate 1siltuximab 1raltitrexed 1pegfilgrastim 1ofatumumab 1niraparib 1leridistim 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1apixaban 1Vorinostat 1Vitamin B 12 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thrombocytopenia × leridistim × Clear all
NCT00004215 2013-06-19

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Classical hematologyOther hematologic neoplasm

Anemia, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Thrombocytopenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡